VITROS CHEMISTRY PRODUCTS AMON SLIDES 1726926

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-03-05 for VITROS CHEMISTRY PRODUCTS AMON SLIDES 1726926 manufactured by Ortho-clinical Diagnostics.

Event Text Entries

[141465269] The investigation determined that a higher than expected vitros ammonia (amon) result was obtained from a single patient sample tested on a vitros 250 chemistry system. The result was higher than expected when compared to the vitros amon result obtained from an alternate sample collected from the same patient, tested on the same vitros 250 chemistry system. The assignable cause of the event is most likely due to improper pre-analytical sample storage of patient sample 1. Patient sample 1 was stored at room temperature for 30 minutes prior to testing. In addition, it is unknown if the plasma was separated from the cellular material within 15 minutes of collection. The vitros amon ifu states that room temperature storage is not recommended. Ammonia is a time sensitive assay due to increase in ammonia concentration as the sample ages. There was no indication the vitros 250 system malfunctioned. Vitros amon precision testing performed was within acceptable guidelines, suggesting an instrument issue was not likely a contributing factor. Additionally, ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros amon slide lot 1018-0249-9334. No historical quality control results were provided, therefore, an unexpected performance issue with vitros amon slide lot 1018-0249-9334 cannot be ruled out as contributing to the event.
Patient Sequence No: 1, Text Type: N, H10


[141465270] A customer obtained a higher than expected vitros ammonia (amon) result from a single patient sample tested on a vitros 250 chemistry system. The result was higher than expected when compared to the vitros amon result obtained from an alternate sample collected from the same patient, tested on the same vitros 250 chemistry system. Patient sample 1 vitros amon result of 725 umol/l vs. The patient sample 2 vitros amon result of 24 umol/l. Biased results of the direction and magnitude observed may lead to inappropriate physician action if undetected. The higher than expected vitros amon result was reported outside the laboratory, but there was no allegation of actual patient harm as a result of this event. This report corresponds to ortho clinical diagnostics inc (ortho). Complaint numbers (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1319809-2019-00013
MDR Report Key8390257
Date Received2019-03-05
Date of Report2019-03-05
Date of Event2019-02-07
Date Mfgr Received2019-02-07
Device Manufacturer Date2018-04-23
Date Added to Maude2019-03-05
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JAMES A STEVENS
Manufacturer Street100 INDIGO CREEK DRIVE
Manufacturer CityROCHESTER NY 14626
Manufacturer CountryUS
Manufacturer Postal14626
Manufacturer Phone5854533000
Manufacturer G1ORTHO-CLINICAL DIAGNOSTICS
Manufacturer Street513 TECHNOLOGY BLVD.
Manufacturer CityROCHESTER NY 14652
Manufacturer CountryUS
Manufacturer Postal Code14652
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameVITROS CHEMISTRY PRODUCTS AMON SLIDES
Generic NameIN-VITRO DIAGNOSTIC
Product CodeJID
Date Received2019-03-05
Catalog Number1726926
Lot Number1018-0249-9334
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerORTHO-CLINICAL DIAGNOSTICS
Manufacturer Address100 INDIGO CREEK DRIVE ROCHESTER NY 14626 US 14626


Patients

Patient NumberTreatmentOutcomeDate
10 2019-03-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.